Dr. Irfan Vaziri
Claim this profileNebraska Hematology - Oncology, P.C.
Studies Plasma Cell Neoplasms
Studies Multiple Myeloma
1 reported clinical trial
4 drugs studied
Affiliated Hospitals
Clinical Trials Irfan Vaziri is currently running
More about Irfan Vaziri
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Irfan Vaziri has experience with
- Dexamethasone Oral
- Elotuzumab
- Pomalidomide
- Selinexor
Breakdown of trials Irfan Vaziri has run
Plasma Cell Neoplasms
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Irfan Vaziri specialize in?
Irfan Vaziri focuses on Plasma Cell Neoplasms and Multiple Myeloma. In particular, much of their work with Plasma Cell Neoplasms has involved treating patients, or patients who are undergoing treatment.
Is Irfan Vaziri currently recruiting for clinical trials?
Yes, Irfan Vaziri is currently recruiting for 1 clinical trial in Lincoln Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Irfan Vaziri has studied deeply?
Yes, Irfan Vaziri has studied treatments such as Dexamethasone Oral, Elotuzumab, Pomalidomide.
What is the best way to schedule an appointment with Irfan Vaziri?
Apply for one of the trials that Irfan Vaziri is conducting.
What is the office address of Irfan Vaziri?
The office of Irfan Vaziri is located at: Nebraska Hematology - Oncology, P.C., Lincoln, Nebraska 68506 United States. This is the address for their practice at the Nebraska Hematology - Oncology, P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.